Back
Cormedix Vs. Brainstorm Cell Therapeutics Industry Stock Comparison
Sell
31
CRMD
Cormedix
Last Price:
9.60
Seasonality Move:
34.02%
Sell
6
BCLI
Brainstorm Cell Therapeutics
Last Price:
1.78
Seasonality Move:
11.28%
Sell
31
Cormedix (CRMD)
is a Sell
Is Cormedix a Buy, Sell or Hold?
- The current Cormedix [CRMD] share price is $9.59. The Score for CRMD is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- CRMD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
6
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?
- The current Brainstorm Cell Therapeutics [BCLI] share price is $1.80. The Score for BCLI is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
- BCLI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CRMD Stock Price Chart
BCLI Stock Price Chart
What is Brainstorm Cell Therapeutics's stock price today?
-
The Brainstorm Cell Therapeutics share price today is $1.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing selling pressure, which indicates risk of future bearish movement.
CRMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.66 | Buy |
| Relative Strength Index (14 RSI): | 44.66 | Sell |
| Chaikin Money Flow: | -1221276 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.8 - 11.94) | Sell |
| Bollinger Bands (100): | (3.94 - 9.08) | Buy |
BCLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.36 | Sell |
| Relative Strength Index (14 RSI): | 29.08 | Sell |
| Chaikin Money Flow: | -42665 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.81 - 2.61) | Sell |
| Bollinger Bands (100): | (2.85 - 5.67) | Sell |
CRMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.47 | Sell |
| 20-day SMA: | 10.88 | Sell |
| 50-day SMA: | 8.52 | Buy |
| 200-day SMA: | 5.44 | Buy |
| 8-day EMA: | 10.78 | Sell |
| 20-day EMA: | 10.55 | Sell |
| 50-day EMA: | 8.94 | Buy |
| 200-day EMA: | 6.13 | Buy |
BCLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.92 | Sell |
| 20-day SMA: | 2.05 | Sell |
| 50-day SMA: | 3.16 | Sell |
| 200-day SMA: | 5.53 | Sell |
| 8-day EMA: | 1.92 | Sell |
| 20-day EMA: | 2.19 | Sell |
| 50-day EMA: | 3.01 | Sell |
| 200-day EMA: | 6.29 | Sell |
Cormedix Earnings Growth & CRMD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and an increase next year of $0.97 per share.
Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.79 per share, and an increase next year of $0.67 per share.
Cormedix Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Brainstorm Cell Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||